Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 6,248 | 15,126 | 5,613 | 9,966 | 4,281 |
| Cost of Goods | 1,558 | 1,358 | 1,317 | 493 | 0 |
| Gross Profit | 4,690 | 13,768 | 4,296 | 9,473 | 4,281 |
| Operating Expenses | 21,134 | 24,841 | 22,729 | 29,059 | 22,516 |
| Operating Income | -15,886 | -10,715 | -18,116 | -19,093 | -18,235 |
| Interest Expense | 915 | 543 | 726 | 607 | 500 |
| Pre-tax Income | -16,801 | -11,258 | -18,842 | -19,700 | -18,735 |
| Net Income Continuous | -16,801 | -11,275 | -18,842 | -19,700 | -18,735 |
| Net Income | $-16,801 | $-11,275 | $-18,842 | $-19,700 | $-18,735 |
| EPS Basic Total Ops | -0.19 | -0.13 | -0.22 | -0.23 | -0.22 |
| EPS Basic Continuous Ops | -0.19 | -0.13 | -0.22 | -0.23 | -0.22 |
| EPS Diluted Total Ops | -0.19 | -0.13 | -0.22 | -0.23 | -0.22 |
| EPS Diluted Continuous Ops | -0.19 | -0.13 | -0.22 | -0.23 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.13 | -0.22 | -0.23 | -0.22 |
| EBITDA(a) | $-15,144 | $-10,116 | $-17,515 | $-18,484 | $-17,678 |